Clinical Trial Update: Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

View source ↗

Summary

Real-world study from Portugal (REVEAL) reports on treatment patterns with cyclin-dependent kinase inhibitors in advanced breast cancer; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)
• KISQALI (ribociclib)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Novartis | Conditions: Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Status: COMPLETED